Kinnate Biopharma Inc. KNTE
Set alert
2.65 +2.65 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 124.99M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -2.55
- Beta
- 1.34
- Short ratio
- 0.96
- Inst. own
- 82.58%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 9, 2024
- 50-d avg
- 2.49
- 200-d avg
- 2.24
- 1y target
- 2.36
Ownership
Held by insiders 0.16%
Held by institutions 82.58%
Float held by institutions 82.71%
Institutions 73
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Foresite Capital Management IV, LLC | 20.54% | 9,671,643 | 29.31M | Jun 29, 2023 |
| Orbimed Advisors LLC. | 17.01% | 8,009,729 | 24.27M | Jun 29, 2023 |
| Foresite Capital Management V, LLC | 7.49% | 3,525,957 | 10.68M | Jun 29, 2023 |
| Nextech Invest Ag | 4.95% | 2,329,480 | 7.06M | Jun 29, 2023 |
| Vida Ventures Advisors, LLC | 4.69% | 2,207,772 | 3.09M | Sep 29, 2023 |
| Lynx1 Capital Management Lp | 4.35% | 2,048,736 | 6.21M | Jun 29, 2023 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.55% | 730,663 | 2.21M | Jun 29, 2023 |
| Fidelity Select Portfolios - Biotechnology | 0.75% | 351,780 | 784.47K | Aug 30, 2023 |
| Vanguard Extended Market Index Fund | 0.46% | 215,647 | 653.41K | Jun 29, 2023 |
| BlackRock Health Sciences Term Trust | 0.42% | 196,773 | 596.22K | Jun 29, 2023 |
| iShares NASDAQ Biotechnology ETF | 0.30% | 139,853 | 311.87K | Aug 30, 2023 |
| Fidelity Extended Market Index Fund | 0.17% | 78,551 | 337.77K | May 30, 2023 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| FORESITE CAPITAL MANAGEMENT IV, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Purchase | May 7, 2023 | 0 |
| GORDON CARL L | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | May 4, 2023 | 0 |
| KRISHNAMOHAN NEHA | Chief Financial Officer | Stock Award(Grant) | Aug 31, 2022 | 69,015 |
| MELTZ MARK A. | Chief Operating Officer | Stock Award(Grant) | Aug 31, 2022 | 28,465 |
| ORBIMED ADVISORS, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Purchase | May 4, 2023 | 0 |
| TANANBAUM JAMES B | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | May 7, 2023 | 0 |
Held by funds
2 US ETFs and mutual funds hold KNTE · largest positions